Repros Therapeutics Inc. News Headlines

RPRX 
$6.31
*  
4.20
39.96%
Get RPRX Alerts
*Delayed - data as of Oct. 17, 2014  -  Find a broker to begin trading RPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
U.S. Hot Stocks: Hot Stocks to Watch
10/17/2014 9:23:00 AM - Dow Jones Business News


Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% - Tale of the Tape
9/29/2014 9:46:00 AM - Zacks.com


5 Breakout Stocks Under $10 Set to Soar
9/26/2014 2:16:00 PM - TheStreet


Sector Update: Health-Care Stocks Mixed Pre-Market
9/26/2014 8:23:00 AM - MT Newswires


Sector Update: Health Care
9/26/2014 8:21:14 AM - MT Newswires


Androxal superior to Androgel in Phase 3 trial
9/26/2014 8:09:00 AM - Seeking Alpha


Repros Granted Type B Pre-NDA Meeting With FDA In First Half Of November
9/26/2014 6:55:00 AM - RTT News


It''s Time To Cross The T''s...
9/19/2014 7:02:00 AM - RTT News


It's Time To Cross The T's...
9/19/2014 7:02:00 AM - RTT News


Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
9/18/2014 8:51:00 AM - Zacks.com


Infoblox Inc Gains On Upbeat Results; The Gap Inc. Shares Decline
9/5/2014 12:36:50 PM - Benzinga


Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
8/28/2014 4:30:00 PM - Zacks.com


Why Repros Therapeutics Inc. Stock Rocketed Higher
8/28/2014 2:38:06 PM - Motley Fool


Williams-Sonoma Dips On Downbeat Q3 Forecast; Signet Jewelers Shares Jump
8/28/2014 12:42:22 PM - Benzinga


Markets Open Lower; Dollar General Profit Matches Street View
8/28/2014 11:15:37 AM - Benzinga


Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% - Tale of the Tape
8/22/2014 9:39:00 AM - Zacks.com


Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog
8/12/2014 10:50:00 AM - Zacks.com


Repros Therapeutics Q2 Loss Widens
8/11/2014 12:35:00 PM - RTT News


Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
7/17/2014 5:20:00 PM - Zacks.com


Repros' Q1 Loss In Line with Expectations - Analyst Blog
5/13/2014 11:00:00 AM - Zacks.com


Commit To Purchase Repros Therapeutics At $12.50, Earn 32.8% Annualized Using Options
4/25/2014 11:44:53 AM - BNK Invest


Monday's ETF Movers: XPH, GDXJ
4/21/2014 2:58:09 PM - BNK Invest


Repros Completes Enrollment for Androxal Study - Analyst Blog
4/15/2014 6:15:01 PM - Zacks.com


Repros Provides Proellex Update - Analyst Blog
3/18/2014 5:10:01 PM - Zacks.com


Narrower-than-Expected Q4 Loss at Repros - Analyst Blog
3/14/2014 9:50:01 AM - Zacks.com